The Scientific Advisory Board is composed of leading epilepsy researchers from both academia and industry with expertise spanning a broad range of disciplines. The SAB members assess grant and investment opportunities and also share their expertise to guide researchers in most effectively advancing new therapy projects. The SAB also provides strategic direction to guide the programs of the organization.
- Gregory Bergey, M.D.: Chairman, Scientific Advisory Board
Professor of Neurology, The Johns Hopkins Epilepsy Center
- Orrin Devinsky, M.D.
Professor of Neurology, Neurosurgery and Psychiatry and Director, NYU Comprehensive Epilepsy Center, New York University
- Ray Dingledine, Ph.D.
Chair, Department of Pharmacology, Emory University
- Robert Fisher, M.D., Ph.D.
Professor of Neurology and Director, Stanford Comprehensive Epilepsy Center, Stanford University
- Jacqueline French, M.D.
Professor of Neurology, NYU Comprehensive Epilepsy Center, New York University; Director Epilepsy Study Consortium
- Brian Litt, M.D.
Assistant Professor of Neurology, Assistant Professor of Bioengineering, University of Pennsylvania
- Daniel H. Lowenstein, M.D.
Professor of Neurology and Director, UCSF Epilepsy Program, University of California, San Francisco
- Steven C. Schachter, M.D.
Professor of Neurology and Director of Research, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center